Background And Objective: An assessment of tuberculosis programmes was carried out in Spain in 1996. The present article looks at trends in tuberculosis control since then.
Material And Method: A questionnaire asking about indicators, referred to year 2000, was sent to Spain's 17 autonomous regions, as well as to the autonomous cities of Ceuta and Melilla. Results were compared with those obtained in 1996.
Results: Improvements, i.e. implementation of more activities, were observed in 77.8% of operative programmes. However, 16.7% of regions have no program yet, while in 27.8% of them, control activities remain scarce. Castilla-León, Catalunya, Ceuta, Madrid, Murcia, Valencia and Galicia were the regions exhibiting more control activities.
Conclusions: Although the trend is positive, many programmes still have a limited effectiveness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0025-7753(03)73954-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mycobacterium tuberculosis (M.tb) infection can lead to various outcomes, including active tuberculosis or latent tuberculosis infection (LTBI). Household contacts of TB cases have a high risk of acquiring LTBI.
View Article and Find Full Text PDFTuberculosis treatment outcomes and associated factors among patients treated at Bosaso TB Hospital, Bosaso, Somalia: A five-year retrospective study.
PLoS One
January 2025
Administration Department, Ministry of Health (Puntland), Bosaso, Puntland, Somalia.
Introduction: Tuberculosis remains a major public health problem, primarily in low- and middle-income countries. Evaluating treatment outcomes and investigating factors associated with them are essential for the treatment and control of tuberculosis. Hence, this study aims to assess the TB treatment outcomes and associated factors in Bosaso, Puntland, Somalia.
View Article and Find Full Text PDFLevel of tuberculosis-related stigma and associated factors in Ugandan communities.
PLoS One
January 2025
Social & Scientific Systems, Inc., a DLH Holdings Company / United States Agency for International Development Strategic Information Technical Support Activity, Kampala, Uganda.
Tuberculosis (TB) stigma remains a significant barrier to TB control efforts globally, especially in countries with a high TB burden. Studies about TB stigma done in Uganda so far have been limited in scope and focused on data collected health facilities. In this study we report TB related stigma at community level for the period 2021/2022.
View Article and Find Full Text PDFA systematic review on malaria and Tuberculosis (TB) vaccine challenges in sub-Saharan African clinical trials.
PLoS One
January 2025
School of Health Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Objective: For more than a century, developing novel and effective vaccines against malaria and Tuberculosis (TB) infections has been a challenge. This review sought to investigate the reasons for the slow progress of malaria and TB vaccine candidates in sub-Saharan African clinical trials.
Methods: The systematic review protocol was registered on PROSPERO on July 26, 2023 (CRD42023445166).
Value of anatomopathological examination in goats with a positive comparative intradermal tuberculin test as part of a tuberculosis control programme.
Vet Rec
January 2025
Departamento de Anatomía y Anatomía Patológica Comparadas, Facultad de Veterinaria, Universidad de Murcia, Murcia, Spain.
Background: Caprine tuberculosis is a chronic infectious disease caused by Mycobacterium bovis and Mycobacterium caprae. A tuberculosis control programme has been implemented using the comparative intradermal tuberculin (CIT) test. However, infection with Corynebacterium pseudotuberculsis and infection with or vaccination against Mycobacterium avium subspecies paratuberculosis (MAP) may have a negative impact on specificity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!